Abbvie Inc

NYSE:ABBVUnited States

AbbVie Inc. is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, and more. The Company, through Mitokinin, Inc., offers a lead compound, PINK1 activator, designed to address mitochondrial dysfunction.

Contact Information

Headquarters

1 N Waukegan RdNORTH CHICAGO, IL, United States 60064

Phone

847-932-7900

Fax

302-655-5049

Executives

Chairman of the Board, Chief Executive Officer

Richard Gonzalez

President, Vice Chairman of the Board, Chief Operating Officer

Robert Michael

Chief Financial Officer, Executive Vice President

Scott Reents

Chief Human Resource Officer, Executive Vice President

Timothy Richmond

Executive Vice President, General Counsel, Company Secretary

Perry Siatis